Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | POLB | P06746 | 1/20 | 0.63 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.48 |
| ▸ | MPO | P05164 | 2/20 | 0.47 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.46 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11334386 | 0.86 | ALDH1A1 (0.68) | KDM4EALDH1A1POLBCHRNA7CYP2A13 | |
| SCHEMBL11196594 | 0.83 | ALDH1A1 (0.69) | KDM4EALDH1A1POLBCHRNA7HRH3 | |
| SCHEMBL11194277 | 0.81 | ALDH1A1 (0.73) | KDM4EALDH1A1POLBCHRNA7CYP2D6 | |
| SCHEMBL30275949 | 0.80 | KDM4E (0.56) | KDM4EALDH1A1POLBCHRNA7CYP2D6 | |
| SCHEMBL2107499 | 0.79 | ALDH1A1 (0.96) | KDM4EALDH1A1POLBCYP2A13HTT | |
| SCHEMBL7862353 | 0.79 | KDM4E (0.51) | KDM4EALDH1A1POLBCYP2D6CYP2C19 | |
| SCHEMBL8667459 | 0.78 | ALDH1A1 (0.58) | KDM4EALDH1A1POLBCHRNA7HRH3 | |
| SCHEMBL29941203 | 0.78 | ALDH1A1 (1.00) | KDM4EALDH1A1POLBCYP2D6CYP2C19 | |
| SCHEMBL29668760 | 0.78 | ALDH1A1 (0.62) | KDM4EALDH1A1POLBCHRNA7CYP2A13 | |
| SCHEMBL21783393 | 0.78 | ALDH1A1 (0.62) | KDM4EALDH1A1POLBCHRNA7CYP2A13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3124490-A1 | HIGH STABILITY POLYIONIC LIQUID SALTS | Sigma-Aldrich Co. LLC (US) | 2017-02-01 | — | — | EP | disclosed |
| US-8481722-B2 | High stability polyionic liquid salts | SIGMA-ALDRICH CO. LLC (US) | 2013-07-09 | — | — | US | disclosed |
| US-20120083603-A1 | HIGH STABILITY POLYIONIC LIQUID SALTS | SIGMA-ALDRICH CO. LLC (US) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083603-A1 | HIGH STABILITY POLYIONIC LIQUID SALTS | PUF60, POLI, PARG | KDM4E 4398/4885ALDH1A1 4720/4885POLB 219/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.